| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |